companydata.dkcompanydata.dk

ORIFARM GENERICS HOLDING A/S: Financial statements 2020

CVR: 27347223

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

ORIFARM GENERICS HOLDING A/S (CVR 27347223) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 12,868,000 and a net result of DKK 114,171,000 compared with EUR 9,696,000 the year before. That is an increase of 664.1% compared with the year before. Equity in the 2020 report amounted to DKK 417,490,000. The solvency ratio was 66.5%.

Gross Profit
DKK 12,868,000
Profit/Loss
DKK 114,171,000
Equity
DKK 417,490,000
Total Assets
DKK 627,598,000
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-12.9M114.2M417.5M0
20190 EUR1.7M EUR9.7M EUR40.6M EUR204
2018-846K EUR5.5M EUR35.9M EUR203
2017-701K EUR8.5M EUR38.5M EUR188
2016-1M EUR9M EUR35M EUR165

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ORIFARM GENERICS HOLDING A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

ORIFARM GENERICS HOLDING A/S: The 2019 annual report is outJun 24, 2020

ORIFARM GENERICS HOLDING A/S has published its annual report for 2019. Revenue came to DKK 0, and the net result was DKK 9,696,000.

About ORIFARM GENERICS HOLDING A/S

ORIFARM GENERICS HOLDING A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named COPYFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Birgitte Bøgh-Sørensen, Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 0 employees (2016). In 2025, the company reported revenue of DKK 459,463,000 and a net result of DKK 273,125,000 compared with DKK 89,363,000 the year before. Equity in the 2025 report amounted to DKK 2,399,752,000.

Source: annual report 2025, Danish Business Authority